Identifying Aging-Modulating Substances via Zip11 Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for addressing aging are limited by regional and safety concerns, and there is a need for new longevity-related genes with excellent potential, as genetic variations such as ApoE, Sirt1, and Foxo3 have shown significant association with longevity but face application limitations.
Innovation Solution
The method involves determining the effect of candidate substances on the activity and/or expression of the Zip11 gene, which is highly expressed in organs like the small intestine, stomach, and liver, and regulating its expression to affect aging, using primers, probes, and reagents to specifically amplify or recognize Zip11 nucleic acid or protein levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If genetic variations such as ApoE, Sirt1, and Foxo3 are used to address aging, then longevity association is improved, but regional limitation and safety concerns worsen
Solution Approach 1:
The patent shifts the focus from genetic variations to substance-induced expression changes of the Zip11 gene. By measuring and modulating the expression level of Zip11 through substance administration, the invention creates a controllable parameter (expression level) that can be adjusted to achieve anti-aging effects without the safety and regional limitations associated with genetic modifications.
Solution Approach 2:
The Zip11 gene expression serves as an intermediary marker and mechanism between substance administration and anti-aging effects. Instead of directly modifying genetics, the patent uses Zip11 expression as a mediating target that responds to substance treatment and subsequently influences aging-related phenotypes, thereby avoiding direct genetic manipulation concerns.
2Adaptability or versatility
If new longevity-related genes are developed, then application potential is improved, but identification and validation complexity worsens
Solution Approach 1:
The patent extracts and focuses on a specific gene (Zip11) that has been identified as having anti-aging potential, rather than attempting to validate multiple candidate genes simultaneously. By isolating the investigation to this single gene with demonstrated expression changes in response to substances, the invention simplifies the validation process while maintaining high application potential.
Solution Approach 2:
The patent replaces complex genetic manipulation and validation systems with a more straightforward substance-expression-measurement approach. Instead of using complex genetic engineering tools to create and validate new longevity genes, the invention uses substance administration followed by expression analysis (e.g., qRT-PCR, Western blot) to identify and validate functional candidates, thereby reducing system complexity.
Data Source
AI summary
Provided is a method for identifying a substance capable of affecting aging, the method comprising: determining the effect of a candidate substance on the activity and/or expression of Zip11; and identifying the candidate substance that changes the activity and/or expression of Zip11 as a substance capable of affecting aging. Further provided is the use of a substance capable of increasing the activity and/or expression quantity of Zip11 for preparing a medicine, wherein the medicine is used for delaying or ameliorating aging.